RT Journal Article
SR Electronic
T1 Portable Objective Diagnostics using Visual Evoked Potentials for Age-related Macular Degeneration
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.01.03.20016451
DO 10.1101/2020.01.03.20016451
A1 Versek, Craig
A1 Banijamali, S. Mohammad Ali
A1 Bex, Peter J.
A1 Lashkari, Kameran
A1 Kamarthi, Sagar V.
A1 Sridhar, Srinivas
YR 2020
UL http://medrxiv.org/content/early/2020/07/06/2020.01.03.20016451.abstract
AB Delayed Dark Adapted vision Recovery (DAR) is a biomarker for Age-related Macular Degeneration (AMD), however its measurement is burdensome for patients and examiners. We developed a portable, wireless, quick-setup system that employs a headset with a smartphone to deliver controlled photobleach and monocular pattern reversal stimuli, while using custom electroencephalography (EEG) electrodes and electronics in order to measure objective Dark Adapted Visual Evoked Potentials (DAVEP) at multiple locations of the visual field - all in one comfortable 20-minute session, without requiring subject reporting. DAVEP responses post photobleach (up to 15 minutes), were measured concurrently in both eyes of 13 patients with AMD and 8 others not diagnosed with AMD. New, unexpected features at high latencies were observed in the DAVEP responses to scotopic stimulus intensities. The amplitude recovery of the DAVEP response was significantly delayed in AMD patients compared with controls. We developed DAVEP1 scores, a simple metric for DAR, using it to successfully identify all 100% of AMD subjects and classify 90% of subject eyes correctly. Deficits in DAR in patients with AMD can be identified using this objective VEP based system and the DAVEP1 metric, a promising new objective biomarker for this disease that can be easily tested in a clinic.Competing Interest StatementSK None. KL None. SAB None. PB Research Support, NeuroFieldz Inc, Newton, MA. CV Research Support, NeuroFieldz Inc, Newton, MA. Patent, Northeastern University SS Research Support, NeuroFieldz Inc, Newton, MA. Patent, Northeastern UniversityFunding StatementWork partially supported by grant HHS-1R41AG057250-01.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesDe-identified data sets may be made available upon request to the corresponding author via email (cversek@gmail.com).